Skip to main content

News & Events

Updates about Leica Biosystems.

csm_Leica_Biosystems
Published: 5 September 2022

(Vista, CA – Sep 5, 2022) Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today announced a partnership focused on delivering compatible…

RNAscope
Published: 30 August 2022

Probes for the CE-IVD marked kit now available for clinical use.  Leica Biosystems, a global leader in pathology workflow solutions, previously partnered with Bio-Techne to create a fully automated, walk-away solution on the BOND-III IHC and ISH stainer, for use in automating RNA ISH. Now, Bio-…

csm_Leica_Biosystems
Published: 29 July 2022

The company’s latest Advanced Staining Solution, BOND-PRIME, is primarily manufactured in Melbourne, Australia MELBOURNE – Leica Biosystems is pleased to announce that the company was a finalist for the 2022 Victorian Manufacturing Hall of Fame Award for Manufacturer of the Year (Large Business).…

BOND-RX-_-NanoString-Geo-MX-DSP-AUTOMATED-PROFILING-Banner
Published: 1 March 2022

SEATTLE, USA and MELBOURNE, AUSTRALIA. March 1st Leica Biosystems continues to advance its relationship with NanoString Technologies Inc., supporting translational research to build confidence in reproducibility and throughput while minimizing manual steps and reducing hands-on time with the…

csm_Leica_Biosystems
Published: 3 February 2022

Solution enables laboratory managers to optimize their tissue processor workflow. NUSSLOCH, GERMANY, FEB 1, 2022. Leica Biosystems is proud to add a new offering to its dualretort tissue processer portfolio: the HistoCore PEGASUS is now available in North American geographies. Building on more than…

csm_Leica_Biosystems
Published: 31 January 2022

CAMBRIDGE, MASS., JANUARY 31, 2022. Companion diagnostic supports patient identification and enrollment into clinical trials of Leap Therapeutics‘ DKK1 inhibitor, DKN-01 Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (Nasdaq: LPTX), a…

Published: 17 December 2021

1 Overview On or about December 10, 2021, a vulnerability was disclosed in the Apache Log4J software, which is a common logging system used by many applications built on Java. The vulnerability is commonly known as “Log4Shell.” More information on this vulnerability is available at https://logging.…

csm_Leica_Biosystems
Published: 2 August 2021

by Chad Salinas, Vice President, AI and Machine Learning Artificial Intelligence is exponentially increasing its impact on healthcare. As deep learning is mastering computer vision tasks, its application to digital pathology is natural, with the promise of aiding in routine reporting and…

leica-biosystems-achieves-first-in-vitro-diagnostics-regulation-certificate
Published: 9 July 2021

Leica Biosystems is on track to align its portfolio of instrumentation and consumables with the In Vitro Diagnostics Regulation (IVDR) that comes into effect May of 2022. Internal technical and operations teams, in partnership with Quality & Regulatory Affairs, are taking steps to ensure that…